Newsfeeds - Spark Newswire

2 minute read

Applied DNA Submits Request For Emergency Use Authorization To FDA For Linea 2.0 COVID-19 Assay And Linea Unsupervised At-Home Sample Collection Kit

Today, 6:55 PM

pplied DNA Sciences, Inc. (NASDAQ:APDN) (the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing and nucleic acid-based technologies, announced today that its wholly-owned clinical

APDN

1 minute read

Watching COVID Testing Plays Following Report US Insurers Have Said They Will Cover Up To 8 Home COVID Tests/Month

By Benzinga Newsdesk

Today, 6:55 PM

-Bloombering citing Associated Press

ABT

1 minute read

FDA
News

White House Says Expects To Have All Contracts For New Rapid Test Awarded Over Next 2 Weeks

By Benzinga Newsdesk

Today, 6:55 PM

-Reuters

ABT

32 minute read

Stocks That Hit 52-Week Lows On Thursday

By Benzinga Insights

Today, 6:55 PM

On Thursday, 615 stocks hit new 52-week lows.

AAOI

1 minute read

News

Applied DNA Sciences Granted U.S Patent #11,214,928 ‘Method of marking cellulosic products’

By Charles Gross

Today, 6:55 PM

View Patent here

APDN

1 minute read

FDA
News

New York City To Double In-School PCR COVID Testing When Students Return

By Benzinga Newsdesk

Today, 6:55 PM

-Reuters

ABT

1 minute read

‘New FDA guidance on rapid tests w/Omicron…’ Mentions Abbott BinaxNOW antigen, Quidel QuickVue antigen, Meridian Bioscience Revogene single target test…Applied DNA Sciences Linea’ -Tweet From Nature Reporter

By Benzinga Newsdesk

Today, 6:55 PM

https://twitter.com/amymaxmen/status/1473736804352278538

ABT

2 minute read

Applied DNA Sciences, Stratum Reservoir Report Memorandum Of Understanding To Leverage Isotopic Analysis For Enhanced DNA-Based Cotton Authenticity, Provenance, No Terms Disclosed

By Benzinga Newsdesk

Today, 6:55 PM

Applied DNA Sciences, Inc. (NASDAQ:APDN) (Applied DNA or the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing and nucleic acid-based technologies, and Stratum Reservoir

APDN

2 minute read

Movers

12 Health Care Stocks Moving In Friday’s After-Market Session

By Benzinga Insights

Today, 6:55 PM

APDN

2 minute read

Earnings

Applied DNA Sciences Earnings Perspective: Return On Capital Employed

By Benzinga Insights

Today, 6:55 PM

Benzinga Pro data, Applied DNA Sciences (NASDAQ:APDN) reported Q4 sales of $3.00 million. Earnings fell to a loss of $4.51 million, resulting in a 30.78% decrease from last quarter.

APDN